Bacteraemia caused by coagulase-negative staphylococci exhibiting decreased susceptibility to teicoplanin

Journal of Hospital Infection

Volumn 51, Issue 3, 2002, Pages 207-214

  Lallemand, S ^a   Thouverez, M ^a   Boisson, K ^a   Talon, D ^a   Bertrand, Xavier ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

Bacteraemia; Coagulase negative staphylococci; Decreased susceptibility to teicoplanin; Molecular epidemiology; Risk factors

Indexed keywords

BACTERIAL DNA; CLINDAMYCIN; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; GENTAMICIN; KANAMYCIN; OFLOXACIN; OXACILLIN; POLYPEPTIDE ANTIBIOTIC AGENT; PRISTINAMYCIN; RIFAMPICIN; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTEREMIA; BACTERIUM CULTURE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONFIDENCE INTERVAL; DNA DETERMINATION; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; PREVALENCE; PULSED FIELD GEL ELECTROPHORESIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RETROSPECTIVE STUDY; REVIEW; STAPHYLOCOCCUS INFECTION; STRAIN DIFFERENCE; ARTICLE; DRUG EFFECT; EPIDEMIOLOGY; GENETICS; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; PATHOGENICITY; RISK FACTOR; STAPHYLOCOCCUS;

ADULT; ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; EPIDEMIOLOGY, MOLECULAR; FEMALE; HUMANS; INCIDENCE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS; TEICOPLANIN;

EID: 0036632190     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhin.2002.1240     Document Type: Article

References (38)

1. Archer, GL (1990). Staphylococcus epidermidis and other coagulase-negative staphylococci. In GL Mandell, RG Douglas, & JE Bennett (Eds.), Principles and Practice of Infectious Diseases, 3rd edn., 1511-1518. New York: Churchill Livingstone, Inc.
2. Pfaller, MA, & Herwaldt, LA (1988). Laboratory, clinical, and epidemiological aspects of coagulase-negative staphylococci. Clin Microbiol Rev, 1 281-299.
3. Archer, GL, & Climo, MW (1994). Antimicrobial susceptibility of coagulase-negative staphylococci. Antimicrob Agents Chemother, 38 2231-2237.
4. Karchmer, AW, Archer, GL, & Dismukes, WE (1983). Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy. Ann Intern Med, 98 447-455.
5. Grant, AC, Lacey, RW, Brownjohn, AM, & Turney, JH (1986). Teicoplanin-resistant coagulase-negative staphylococcus. Lancet, 2 1166-1167.
6. Goldstein, FW, Coutrot, A, Sieffer, A, & Acar, JF (1990). Percentages and distribution of teicoplanin- and vancomycin-resistant strains among coagulase-negative staphylococci. Antimicrob Agents Chemother, 34 899-900.
7. Wilson, AP, O'Hare, MD, Felmingham, D, & Grüneberg, RN (1986). Teicoplanin-resistant coagulase-negative staphylococcus. Lancet, 2 973.
8. Murphy, OM, Stewart, D, Gray, J, & Bint, AJ (1996). Susceptibility of staphylococci to teicoplanin and vancomycin. J Antmicrob Chemother, 38 316-317.
9. Weiss, K, Rouleau, D, & Laverdière, M (1996). Cystitis due to vancomycin-intermediate Staphylococcus saprophyticus. J Antimicrob Chemother, 37 1039-1040.
10. Sanyal, D, Johnson, AP, George, RC, Cookson, BD, & Williams, AJ (1991). Peritonitis due to vancomycin-resistant Staphylococcus epidermidis. Lancet, 337 54.
11. Kremery, V, Trupl, J, Drgona, L, Lacka, J, Kukuckova, E, & Oravcova, E (1996). Nosocomial bacteraemia due to vancomycin-resistant Staphylococcus epidermidis in four patients with cancer, neotropenia, and previous treatment with vancomycin. Eur J Clin Microbiol Infect Dis, 15 259-261.
12. Garrett, DO, Jochimsen, E, & Murfitt, K et al. (1999). The emergence of decreased susceptibility to vancomycin in Staphylococcus epidermidis. Infect Control Hosp Epidemiol, 20 167-170.
13. Spanik, S, Trupl, J, Studena, M, & Krcmery, V (1997). Breakthrough nosocomial bacteraemia due to teicoplanin-resistant Staphylococcus haemolyticus in five patients with acute leukaemia. J Hosp Infect, 35 155-159.
14. Garner, JS, Jarvis, WR, & Emori, TG et al. (1988). CDC definitions for nosocomial infections, 1988. Am J Infect Control, 16 128-140.
15. Report of the Comit́e de l'Antibiogramme de la Société Française de Microbiologie. Clin Microbiol Infect 1996 2 (Suppl. 1)
16. Mainardi, JL, Shlaes, DM, Goering, RV, Shlaes, JH, Acar, JF, & Goldstein, FW (1995). Decreased teicoplanin susceptibility of methicillin resistant strains of Staphylococcus aureus. J Infect Dis, 171 1646-1650.
17. Prevost, G, Jaulhac, B, & Piemont, Y (1992). DNA fingerprinting by pulsed-field gel electrophoresis is more effective than ribotyping in distinguishing among methicillin-resistant Staphylococcus aureus isolates. J Clin Microbiol, 30 967-973.
18. Struelens, MJ, Bax, R, Deplano, A, Quint, WG V, & van Belkum, A (1993). Concordant clonal delineation of methicillin-resistant Staphylococcus aureus by macrorestriction analysis and polymerase chain reaction genome fingerprinting. J Clin Microbiol, 31 1964-1970.
19. Tenover, FC, Arbeit, RD, & Goering, RV et al. (1995). Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol, 33 2233-2239.
20. Natsch, S, Hekster, YA, de Jong, R, Heerdink, ER, Herings, RM, & van der Meer, JW (1998). Application of the ATC/DDD methodology to monitor antibiotic drug use. Eur J Clin Microbiol Infect Dis, 17 20-24.
21. Edmond, MB, Wallace, SE, McClish, DK, Pfaller, MA, Jones, RN, & Wenzel, RP (1999). Nosocomial bloodstreal infections in United States Hospitals: a three-year analysis. Clin Infect Dis, 29 239-244.
22. Gerberding, J, Gaynes, R, Horan, T, Abshire, J, Alonso-Echanove, J, & Edwards, J (1999). National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990-May 1999, issued June 1999. Am J Infect Control, 27 520-532.
23. Lark, RL, Chenoweth, C, Saint, S, Zemencuk, JK, Lipsky, BA, & Plorde, JJ (2000). Four year prospective evaluation of nosocomial bacteraemia: epidemiology, microbiology, and patient outcome. Diagnostic Microbiol Infect Dis, 38 131-140.
24. Del'Alamo, L, Cereda, RF, Tosin, I, Miranda, EA, & Sader, HF (1999). Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides. Diagnostic Microbiol Infect Dis, 34 185-191.
25. Veach, LA, Pfaller, MA, Barrett, M, Koontz, FP, & Wenzel, RP (1990). Vancomycin resistance in Staphylococcus haemolyticus causing colonization and bloodstream infection. J Clin Microbiol, 28 2064-2068.
26. Cercenado, E, Garcia-Leoni, ME, & Diaz, MP et al. (1996). Emergence of teicoplanin-resistant coagulase-negative staphylococci. J Clin Microbiol, 34 1765-1768.
27. Sloos, JH, van de Klundert, JA M, Dijkshoorn, L, & van Boven, CP A (1998). Changing susceptibilities of coagulase-negative staphylococci to teicoplanin in a teaching hospital. J Antimicrob Chemother, 42 787-791.
28. Woodford, N, Johnson, AP, Morrisson, D, & Speller, DC E (1995). Current perspectives on glycopeptide resistance. Clin Microbiol Rev, 8 585-615.
29. Biavasco, F, Vignaroli, C, & Varaldo, PE (2000). Glycopeptide resistance in coagulase-negative staphylococci. Eur J Clin Microbiol Infect Dis, 19 403-417.
30. Jansen, B, Schumacher-Perdreau, F, & Pulverer, G (1995). Susceptibility of staphylococci and enterococci to glycopeptides: comparison of three test methods. Zentralblatt für Bakteriologie, 282 402-408.
31. Fainstein, V, LeBlanc, B, & Bodey, GP (1983). Comparative in vitro study of teichomycin A2. Antimicrob Agents Chemother, 23 497-499.
32. Neu, HC, & Labthavikul, P (1983). In vitro activity of teichomycin compared with those of other antibiotics. Antimicrob Agents Chemother, 24 425-428.
33. Tuazon, CU, & Miller, H (1984). Comparative in vitro activities of teichomycin and vancomycin alone and in combination with rifampicin and aminoglycosides against staphylococci and enterococci. Antimicrob Agents Chemother, 25 411-412.
34. Vermont, CL, Hartwig, NG, & Fleer, A et al.(1998). Persistence of clones of coagulase-negative staphylococci among premature neonates in neonatal intensive care units: two-center study of bacterial genotyping and patient risk factors. J Clin Microbiol, 36 2485-2490.
35. Villari, P, Sarnataro, C, & Iacuzio, L (2000). Molecular epidemiology of Staphylococcus epidermidis in a neonatal intensive care unit over a three-year period. J Clin Microbiol, 38 1740-1746.
36. Lang, S, Livesley, MA, Lambert, PA, Elliott, J, & Elliott, TS (1999). The genomic diversity of coagulase-negative staphylococci associated with nosocomial infections. J Hosp Infect, 43 187-193.
37. Floret, N, Thouverez, M, Thalamy, B, Estavoyer, JM, & Talon, D (2001). Evaluation of vancomycin use in a large university-affiliated hospital in eastern France in 1999. Pham World Sci, 23 93-97.
38. Sieradzki, K, Roberts, RB, Serur, D, Hargrave, J, & Tomasz, A (1998). Recurrent peritonitis in a patient on dialysis and prophylactic vancomycin. Lancet, 351 880-881.